DarioHealth Corp.
DarioHealth Corp. (DRIO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
drio · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for DarioHealth Corp. (DRIO) measures how much investors pay for each dollar of the company's trailing earnings. DRIO's current PE ratio of 5.87x is calculated by dividing its stock price of $7.48 by its TTM earnings per share of $1.26.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
DarioHealth Corp.You DRIO | $55M | 5.87x | — | $1.26 |
 Absci Corporation ABSI | $1.0B | N/A | — | -$0.84 |
 Avanos Medical, Inc. AVNS | $1.2B | N/A | — | -$1.46 |
 Fulgent Genetics, Inc. FLGT | $531M | N/A | — | -$1.97 |
 InnovAge Holding Corp. INNV | $994M | N/A | — | -$0.22 |
 Myriad Genetics, Inc. MYGN | $416M | N/A | — | -$3.92 |
 Anbio Biotechnology Class A Ordinary Shares NNNN | $805M | 182.63x | — | $0.16 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.84 | — | |
2024-12-31 FY2024 | — | $-1.06 | — | |
2023-12-31 FY2023 | — | $-2.09 | — | |
2022-12-31 FY2022 | — | $-2.63 | — | |
2021-12-31 FY2021 | — | $-4.63 | — | |
2020-12-31 FY2020 | — | $-4.94 | — | |
2019-12-31 FY2019 | — | $-7.83 | — | |
2018-12-31 FY2018 | — | $-15.21 | — | |
2017-12-31 FY2017 | — | $-32.70 | — | |
2016-12-31 FY2016 | — | $-41.85 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for DarioHealth Corp. (DRIO) measures how much investors pay for each dollar of the company's trailing earnings. DRIO's current PE ratio of 5.87x is calculated by dividing its stock price of $7.48 by its TTM earnings per share of $1.26.
Frequently asked questions
DRIO pe ratio · 6 questionsDRIO's current PE ratio is 5.87x as of 2026-06-08, based on a stock price of $7.48 and TTM EPS of $1.26. Data sourced from Financial Modeling Prep via DRIO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DarioHealth Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08